10.1136/heartjnl-2011-300893
Journal article
2012-03-01T00:00:00+00:00
98
345 - 348
3
Aged, Androgen Antagonists, Cardiovascular Diseases, Humans, Incidence, Male, Prostatic Neoplasms, Risk Assessment, Risk Factors, Survival Rate, United Kingdom